Michael Vitoldovich Paukshto
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 16, 2021 | NIH | SBIR Phase II Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $682K | Fibralign Corporation |
| Aug 31, 2020 | NIH | SBIR Phase II Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $33K | Fibralign Corporation |
| Sep 12, 2019 | NIH | SBIR Phase II Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $253K | Fibralign Corporation |
| Aug 6, 2019 | NIH | SBIR Phase II Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $2K | Fibralign Corporation |
| Aug 18, 2017 | NIH | SBIR Phase II Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | $998K | Fibralign Corporation |
Peer ranks
Federal funding#1,199
Awards as PI#470
Patents#505
Companies
- Fibralign CorporationLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.